NanoViricides Inc. (NNVC)

[iThink]

About this Teri Buhl..I read the article that she wrote when it first came out. I have a HUGE problem with it:
(1) “Shaquoia Garo, from Columbia University-College of Physician and Surgeons, confirms in an email NanoViricides cofounder Eugene Seymour did not receive a medical degree from the University.”

I would like see a copy of this so-called letter from Shaquoia Garo. I supposed that we could call her. BUT…

(2) “When the news first showed up as a possible allegation on Seeking Alpha today the company took down it’s website at the 3pm hour while trading in the stock was still going on. The company bio was edited today and the NanoVircides website was back online after the market closed. Where Seymour got his medical training is now a vague line on his bio.”

This is INCORRECT. How do I know? I have COPIES of his bios on the website PRIOR to this year, say, at least 2 years prior. It goes something like (There were two separate ones over the years):

“Eugene Seymour, MD, MPH, age 69, has been Chief Executive Officer (CEO) and a director of the Company since consummation of the merger on June 1, 2005. From 1996 until May 2005 he has been a private investor and has held no corporate positions. During this period he formed a non-profit foundation which funded both testing and training programs for health workers in Asia and Africa. He was a consultant to the UN Global Program on AIDS and was sent to several countries, (Lithuania, Latvia, Estonia and Russia) to interact with local physicians and assist them in setting up testing programs. Dr. Seymour obtained a Master's degree in the Epidemiology of Infectious Diseases at UCLA in addition to his medical degree. He began clinical practice in Internal Medicine and joined the UCLA Medical School faculty. He left UCLA after two years and joined the USC faculty as Associate Professor. Dr. Seymour served in the Medical Corps of US Army Reserve during the Vietnam era and attained the rank of Major. In 1986, he was requested by the US government to establish a testing laboratory and run a large-scale surveillance program for HIV prevalence in the Hispanic population in Los Angeles. His laboratory ended up testing over 50,000 people. In 1989, he founded StatSure Diagnostic Systems, Inc. (SDS) (formerly Saliva Diagnostic Systems, Inc.), raised capital and developed the rapid HIV antibody blood test (Hema-Strip). He took the company public in 1993 as CEO and President. He left SDS in 1996. Dr. Seymour holds 8 issued patents, and is married with three children, two of whom are physicians.”

“Dr. Seymour began practicing medicine in Los Angeles/ Beverly Hills in the late 1960's. In late 1981, he began treating patients with a strange new disease affecting primarily the gay population. In 1986, he was requested by the US government to establish a testing laboratory and run a large-scale surveillance program for HIV prevalence in the Hispanic population in Los Angeles. His laboratory ended up testing over 50,000 people. Because of his belief that prevention, in the absence of a cure, was critical to stem the rising tide of HIV infections, he founded a company, now called Stat-Sure, Inc, in 1989. He raised the capital and oversaw the development of a rapid HIV antibody blood test (Hema-Strip). In 1993, as Chief Executive Officer, he took the company public as a NASDAQ company. Under his direction, the company conducted research studies in Africa, Asia, South and North America. The Hema-Strip was approved in a number of countries including Canada, Great Britain and Vietnam. Dr. Seymour left the company in 1996 to run a non-profit foundation, which funded both testing and training programs for health workers in Asia and Africa. He became a consultant to the UN Global Program on AIDS and was sent to a number of different countries, (Lithuania, Latvia, Estonia and Russia) to interact with local physicians and assist them in setting up testing programs. Two years later, he became Director of Strategic Alliances at a medical education startup called medschool.com that was later acquired by a group of investors.
Dr. Seymour is the holder of 8 issued patents. Originally trained as a chemist, he decided to attend medical school in preparation for a career as a clinical investigator. Following postgraduate medical training, he obtained a Master's degree in the Epidemiology of Infectious Diseases at UCLA. He began clinical practice in Internal Medicine and joined the UCLA Medical School faculty. He left UCLA after two years and joined USC faculty as Associate Professor. He served in the Medical Corps of US Army Reserve during the Vietnam era and attained the rank of Major."

The truth is that the whole "Columbia University" thing was never on his website profile to begin with. Now LinkedIn...and other places, "yes."

(3) Eugene Seymour DIDN'T bother trying to change his LinkedIn bios: http://www.linkedin.com/pub/eugene-seymour-md-mph/5/303/63

It still says:

Eugene Seymour, MD, MPH's Overview
Current Chief Executive Officer at Nanoviricides.com
Education Columbia University College of Physicians and Surgeons
Baylor College of Medicine
David Geffen School of Medicine at UCLA
Connections
398 connections

You would think that if he did change his profile on Nanoviricides that he would change it on his LinkedIn profile as well.

I am starting to get a really good idea who might be SHORTING the stock.